Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Netflix | NFLX | Nov 1, 2024 | 756.10 | +0.01 |
NETGEAR | NTGR | Nov 1, 2024 | 22.78 | +3.92 |
Netherlands Invstbl Mkt Idx MSCI Ishares | EWN | Nov 1, 2024 | 46.69 | +0.04 |
NetScout Systems | NTCT | Nov 1, 2024 | 20.46 | -2.71 |
NETSOL Technologies | NTWK | Nov 1, 2024 | 3.03 | +2.02 |
Netstreit | NTST | Nov 1, 2024 | 15.28 | -1.42 |
Network-1 Technologies | NTIP | Nov 1, 2024 | 1.28 | -1.54 |
Neuberger Berman | NML | Nov 1, 2024 | 8.23 | -0.60 |
Neuberger Berman High Yield Strategies Fund | NHS | Nov 1, 2024 | 8.04 | -1.95 |
Neuberger Berman Municipal Fund | NBH | Nov 1, 2024 | 10.78 | -0.55 |
Neuberger Berman Next Generation Connectivity Fund | NBXG | Nov 1, 2024 | 12.78 | +1.91 |
Neuberger Berman Real Estate Securities Income Fund | NRO | Nov 1, 2024 | 3.85 | -1.53 |
NeueHealth | NEUE | Nov 1, 2024 | 5.11 | -0.58 |
Neumora Therapeutics | NMRA | Nov 1, 2024 | 11.17 | -2.45 |
Neuraxis | NRXS | Nov 1, 2024 | 2.59 | -3.71 |
Neurobo Pharmaceuticals | NRBO | Nov 1, 2024 | 2.67 | +3.89 |
Neurocrine Biosciences | NBIX | Nov 1, 2024 | 122.21 | +1.61 |
Neurogene | NGNE | Nov 1, 2024 | 46.07 | +4.68 |
NeuroMetrix | NURO | Nov 1, 2024 | 4.00 | -0.36 |
Neuronetics | STIM | Nov 1, 2024 | 1.03 | 0.00 |
NeuroOne | NMTC | Nov 1, 2024 | 0.94 | -3.09 |
Neuropace | NPCE | Nov 1, 2024 | 6.29 | -2.48 |
NeuroSense Therapeutics | NRSN | Nov 1, 2024 | 1.27 | +1.59 |
Nevro | NVRO | Nov 1, 2024 | 5.53 | +0.36 |
New America High Income Fund | HYB | Nov 1, 2024 | 8.19 | +0.12 |
New Concept Energy | GBR | Nov 1, 2024 | 1.21 | -1.63 |
New England Realty Associates LP Unit A | NEN | Nov 1, 2024 | 82.50 | 0.00 |
New Fortress Energy A | NFE | Nov 1, 2024 | 8.00 | -4.88 |
New Found Gold | NFGC | Nov 1, 2024 | 2.24 | -0.44 |
New Germany Fund | GF | Nov 1, 2024 | 8.48 | +0.24 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.